ISSN: 1521-6926

Journal Home

Journal Guideline

Best Practice and Research in Clinical Haematology Q2 Unclaimed

United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Best Practice and Research in Clinical Haematology is a journal indexed in SJR in Oncology and Clinical Biochemistry with an H index of 81. It has an SJR impact factor of 0,864 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,864.

Best Practice and Research in Clinical Haematology focuses its scope in these topics and keywords: myeloid, tnkcell, transplantation, treatment, therapy, cell, solid, tcell, tumourshost, peripheral, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Clinical Biochemistry (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Best Practice and Research in Clinical Haematology

0,864

SJR Impact factor

81

H Index

50

Total Docs (Last Year)

147

Total Docs (3 years)

3477

Total Refs

343

Total Cites (3 years)

138

Citable Docs (3 years)

2.11

Cites/Doc (2 years)

69.54

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
BMC Cancer Q2
Cancer Epidemiology Q2
Frontiers in Oncology Q2
Journal of Geriatric Oncology Q2

Compare this journals

Aims and Scope

Best articles by citations

Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia

Autologous peripheral blood progenitor cell transplantation for multiple myeloma

Autologous peripheral blood stem cell transplantation for acute leukaemias

Safety and efficacy in retrovirally modified haematopoietic cell therapy

Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts

Autologous peripheral blood stem cell transplantation for lung cancer

Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

Preface

Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia

Cord blood stem cell transplantation

Ex vivo expansion of mobilized peripheral blood stem cells

Venous thromboembolism in neonates and children

SHOW MORE ARTICLES

Iron and infection: competition between host and microbes for a precious element

Immunological recovery and tumour-specific immunotherapeutic approaches to post-autologous haematopoietic stem cell transplantation

Importance of biologic follow-ons: experience with EPO

Treatment of acute myeloid leukaemia in younger patients

Preface

Disseminated intravascular coagulation and purpura fulminans secondary to infection

Preface

Oral iron chelators -development and application

Negative selection of autologous peripheral blood stem cells

Red blood cell substitutes

Assessing disease burden in patients with classic MPNs

Normal and leukaemic haematopoiesis in bone marrow and peripheral blood of patients with chronic myeloid leukaemia

Best Practice and Research in Clinical Haematology Q2 Unclaimed

- €

NPD

0 €

Metrics

0,864

81

50

147

3477

343

138

2.11

69.54

Comments

Other journals with similar parameters

Aims and Scope

Best articles by citations

FAQS

What is the impact factor of Best Practice and Research in Clinical Haematology?